Influence of gut microbiome on multiple myeloma: friend or foe?
Multiple myeloma (MM) is a malignancy of terminally differentiated plasma cells, which typically evolves over time from its precursor, monoclonal gammopathy of undetermined significance. While the underlying mechanisms of this evolution remain elusive, immunomodulatory factors affecting the bone mar...
Main Authors: | Nausheen Ahmed, Mahmoud Ghannoum, Molly Gallogly, Ehsan Malek |
---|---|
Format: | Article |
Language: | English |
Published: |
BMJ Publishing Group
2020-06-01
|
Series: | Journal for ImmunoTherapy of Cancer |
Online Access: | https://jitc.bmj.com/content/8/1/e000576.full |
Similar Items
-
The Gut Microbiome in Anorexia Nervosa: Friend or Foe?
by: Ana Ghenciulescu, et al.
Published: (2021-01-01) -
Correction: Inhibition of TGF-β-receptor signaling augments the antitumor function of ROR1-specific CAR T-cells against triple-negative breast cancer
by: Nausheen Ahmed, et al.
Published: (2020-06-01) -
The Immune Microenvironment in Multiple Myeloma: Friend or Foe?
by: Raquel Lopes, et al.
Published: (2021-02-01) -
The Microbiome of the Nose—Friend or Foe?
by: Sofia Dimitri-Pinheiro MD, et al.
Published: (2020-03-01) -
The oral microbiome – friend or foe?
by: Kilian, M.
Published: (2018)